Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial
Autor: | Stefan Nehrer, Astrid Fahrleitner-Pammer, Andreas Kurth, R. Ljuhar, Hans Peter Dimai, D. Ljuhar, B. Norman |
---|---|
Rok vydání: | 2018 |
Předmět: |
musculoskeletal diseases
medicine.medical_specialty Osteoporosis Urology Pilot Projects 030218 nuclear medicine & medical imaging law.invention 03 medical and health sciences Absorptiometry Photon 0302 clinical medicine Lumbar Randomized controlled trial Bone Density law medicine Humans Scientific Article Radiology Nuclear Medicine and imaging Osteoporosis Postmenopausal Aged Aged 80 and over 030203 arthritis & rheumatology Bone mineral Lumbar Vertebrae Bone Density Conservation Agents business.industry Long-term treatment Reproducibility of Results Repeated measures design Middle Aged medicine.disease Dual X-ray absorptiometry (DXA) Bone structure value (BSV) Treatment Outcome Denosumab Orthopedic surgery Cohort Radiographic Image Interpretation Computer-Assisted Female business Software Conventional radiograph medicine.drug |
Zdroj: | Skeletal Radiology |
ISSN: | 1432-2161 0364-2348 |
DOI: | 10.1007/s00256-018-3118-y |
Popis: | Objective To evaluate the clinical applicability of a software tool developed to extract bone textural information from conventional lumbar spine radiographs, and to test it in a subset of postmenopausal women treated for osteoporosis with the fully human monoclonal antibody denosumab. Methods The software was developed based on the principles of a fractal model using pixel grey-level variations together with a specific machine-learning algorithm. The obtained dimensionless parameter, termed bone structure value (BSV), was then tested and compared to bone mineral density (BMD) in a sub-cohort of postmenopausal women with osteoporosis who were treated with the monoclonal antibody denosumab, within the framework of a large randomized controlled trial and its open-label extension phase. Results After 3 years and after 8 years of treatment with denosumab, mean lumbar spine BMD as well as mean lumbar BSV were significantly higher compared to study entry (one-way repeated measures ANOVA for DXA: F = 108.2, p |
Databáze: | OpenAIRE |
Externí odkaz: |